Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipients

HBV reactivation in allogeneic stem cell transplant recipients: risk factors, outcome and role of HBV mutations

Zeitschrift für Gastroenterologie ◽

10.1055/s-0037-1612891 ◽

2018 ◽

Vol 56 (01) ◽

pp. E2-E89 ◽

Cited By ~ 1

Author(s):

O Anastasiou ◽

F Almpani ◽

A Herrmann ◽

G Gerken ◽

M Ditschkowski ◽

...

Keyword(s):

Risk Factors ◽

Stem Cell ◽

Stem Cell Transplant ◽

Hbv Reactivation ◽

Cell Transplant ◽

Management of Allogeneic Stem Cell Transplant Recipients with Hepatic Veno-Occlusive Disease

Global Journal of Hematology and Blood Transfusion ◽

10.15379/2408-9877.2017.04.01.01 ◽

2017 ◽

Vol 4 (1) ◽

Author(s):

Alessandro Busca

Keyword(s):

Stem Cell ◽

Stem Cell Transplant ◽

Occlusive Disease ◽

Cell Transplant ◽

Common seasonal respiratory virus infections in allogeneic stem cell transplant recipients during the SARS-COV-2 pandemic

Bone Marrow Transplantation ◽

10.1038/s41409-021-01319-5 ◽

2021 ◽

Author(s):

Rosalía De la Puerta ◽

Juan Montoro ◽

Carla Aznar ◽

Ignacio Lorenzo ◽

Eva María González-Barberá ◽

...

Keyword(s):

Stem Cell ◽

Respiratory Virus ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Transplant Recipients ◽

Virus Infections ◽

Respiratory Virus Infections

Transfusion in CMV seronegative T-depleted allogeneic stem cell transplant recipients with CMV-unselected blood components results in zero CMV transmissions in the era of universal leukocyte reduction: a UK dual centre experience

Transfusion Medicine ◽

10.1111/tme.12219 ◽

2015 ◽

Vol 25 (6) ◽

pp. 418-423 ◽

Cited By ~ 10

Author(s):

S. Hall ◽

R. Danby ◽

H. Osman ◽

A. Peniket ◽

V. Rocha ◽

...

Keyword(s):

Stem Cell ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Blood Components ◽

Utilizing Data to Modify Standard Operating Procedures and Improve Outcomes: Evaluating Complications after Donor Lymphocyte Infusions in Allogeneic Stem Cell Transplant Recipients

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2018.12.412 ◽

2019 ◽

Vol 25 (3) ◽

pp. S128-S129

Author(s):

Kimberly A. Kasow ◽

Jennifer E. Brondon ◽

Paul M. Armistead ◽

Jonathan S. Serody ◽

Benjamin G Vincent ◽

...

Keyword(s):

Stem Cell ◽

Stem Cell Transplant ◽

Standard Operating Procedures ◽

Cell Transplant ◽

Transplant Recipients ◽

Standard Operating ◽

Donor Lymphocyte Infusions

Epidemiology of Invasive Mold Infections in Allogeneic Stem Cell Transplant Recipients: Biological Risk Factors for Infection According to Time after Transplantation

Clinical Infectious Diseases ◽

10.1086/591969 ◽

2008 ◽

Vol 47 (8) ◽

pp. 1041-1050 ◽

Cited By ~ 235

Author(s):

Carol Garcia‐Vidal ◽

Arlo Upton ◽

Katharine A. Kirby ◽

Kieren A. Marr

Keyword(s):

Risk Factors ◽

Stem Cell ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Transplant Recipients ◽

Biological Risk ◽

Invasive Mold Infections

Whole Exome Sequencing and in silico Determination of the Magnitude of Alloreactive Antigen Presentation on HLA DRB1 in Allogeneic Stem Cell Transplant Recipients

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2016.12.339 ◽

2017 ◽

Vol 23 (3) ◽

pp. S199-S200

Author(s):

Ali Raied Salman ◽

Vishal N. Koparde ◽

Charles E. Hall ◽

David J. Kobulnicky ◽

Allison F. Scalora ◽

...

Keyword(s):

Stem Cell ◽

Exome Sequencing ◽

Whole Exome Sequencing ◽

In Silico ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Transplant Recipients ◽

Whole Exome

Alternate day ganciclovir and foscarnet is safe and effective in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2005.11.419 ◽

2006 ◽

Vol 12 (2) ◽

pp. 136-137

Author(s):

E. Shereck ◽

O. Militano ◽

E. Cooney ◽

C. van de Ven ◽

Y.K.K. Cheung ◽

...

Keyword(s):

At Risk ◽

Stem Cell ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Clinical Validation of Dried Blood Spot Sampling in Therapeutic Drug Monitoring of Ciclosporin A in Allogeneic Stem Cell Transplant Recipients

Therapeutic Drug Monitoring ◽

10.1097/ftd.0b013e31827d76ce ◽

2013 ◽

Vol 35 (1) ◽

pp. 92-95 ◽

Cited By ~ 18

Author(s):

Abraham J. Wilhelm ◽

Adinda Klijn ◽

Jeroen C. G. den Burger ◽

Otto J. Visser ◽

Agnes I. Veldkamp ◽

...

Keyword(s):

Stem Cell ◽

Therapeutic Drug Monitoring ◽

Stem Cell Transplant ◽

Therapeutic Drug ◽

Cell Transplant ◽

Clinical Validation ◽

Transplant Recipients ◽

Ciclosporin A ◽

Blood Spot

CYTOMEGALOVIRUS REACTIVATION IN ALLOGENEIC STEM CELL TRANSPLANT RECIPIENTS: FREQUENCY, TIME TO REACTIVATION AND DYNAMIC OF VIREMIA IN DIFFERENT TYPES OF DONORS AND IN REPEATED EPISODES

Hematology Transfusion and Cell Therapy ◽

10.1016/j.htct.2020.10.484 ◽

2020 ◽

Vol 42 ◽

pp. 291

Author(s):

M. Garnica ◽

S. Dalcomo ◽

B.L. Gaio ◽

I. Alves ◽

M.R. Valetim ◽

...

Keyword(s):

Stem Cell ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Transplant Recipients ◽

Cytomegalovirus Reactivation ◽

Different Types